| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $57K | -78.9% |
| Cost of Revenue | $40K | -60.9% |
| Gross Profit | $17K | -89.9% |
| R&D Expense | $246K | -77.8% |
| SG&A Expense | $4.3M | -27.5% |
| Operating Income | -$4.5M | +58.2% |
| Interest Expense | $18K | — |
| Pre-tax Income | -$4.6M | +56.7% |
| Income Tax | $24K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.1M | -34.6% |
| Accounts Receivable | $18K | +0.0% |
| Current Assets | $3.5M | -27.4% |
| Total Assets | $3.5M | -27.5% |
| Current Liabilities | $26K | -91.8% |
| Total Liabilities | $26K | -91.8% |
| Stockholders' Equity | $11.4M | -4.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.0M | +9.9% |
| Investing Cash Flow | -$15K | +0.0% |
| Financing Cash Flow | $3.3M | -63.8% |
| — |
| Net Income | -$4.0M | +61.5% |
| EPS (Basic) | -$1.54 | +85.2% |
| EPS (Diluted) | -$1.54 | +85.2% |